In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...

take note of the cold reception Pfizer CEO Albert Bourla got at the White House, and more. From STAT’s Jason Mast: Bluebird Bio announced this morning it would sell itself and its portfolio of ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of Directors Pharmaceutical Research and Manufacturers of America (PhRMA) Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

Pfizer CEO Albert Bourla discusses the major mobilization to deliver a Covid-19 vaccine in record speed, and what it means for medical research, with WSJ's health and science coverage chief ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Its high debt load remained a cause of investor concern for the entire year, and as a result, CEO Albert Bourla's turnaround strategy is now a key part of Pfizer Inc. (NYSE:PFE)'s hypothesis.